Sara Steffanoni

735 total citations
26 papers, 265 citations indexed

About

Sara Steffanoni is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Sara Steffanoni has authored 26 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 15 papers in Neurology and 10 papers in Oncology. Recurrent topics in Sara Steffanoni's work include Lymphoma Diagnosis and Treatment (19 papers), CNS Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sara Steffanoni is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), CNS Lymphoma Diagnosis and Treatment (15 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sara Steffanoni collaborates with scholars based in Italy, United States and Switzerland. Sara Steffanoni's co-authors include Teresa Calimeri, Andrés J.M. Ferreri, A. Chiara, Filippo Gagliardi, Giovanni Martinelli, Emanuele Zucca, Giancarlo Pruneri, Pier Luigi Zinzani, Luca Nassi and Simona Sammassimo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Sara Steffanoni

22 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Steffanoni Italy 7 176 114 82 72 36 26 265
Donato Mannina Italy 9 193 1.1× 76 0.7× 56 0.7× 80 1.1× 8 0.2× 24 292
Ingrid Vášová Czechia 7 192 1.1× 78 0.7× 59 0.7× 153 2.1× 9 0.3× 35 293
Xanthi Yiakoumis Greece 11 193 1.1× 40 0.4× 99 1.2× 100 1.4× 10 0.3× 25 259
Hanno M. Witte Germany 10 141 0.8× 50 0.4× 72 0.9× 197 2.7× 15 0.4× 35 309
Zdravko Mitrović Croatia 10 160 0.9× 29 0.3× 95 1.2× 117 1.6× 10 0.3× 30 255
Lenka Šmardová Czechia 9 256 1.5× 125 1.1× 42 0.5× 220 3.1× 10 0.3× 28 407
Annalisa Gabriele Italy 8 255 1.4× 87 0.8× 88 1.1× 112 1.6× 5 0.1× 12 315
Avyakta Kallam United States 9 102 0.6× 16 0.1× 66 0.8× 104 1.4× 18 0.5× 52 249
Shankaranarayana Paneesha United Kingdom 8 57 0.3× 58 0.5× 36 0.4× 67 0.9× 13 0.4× 21 284
Annalisa Arcari Italy 11 159 0.9× 57 0.5× 69 0.8× 166 2.3× 4 0.1× 24 272

Countries citing papers authored by Sara Steffanoni

Since Specialization
Citations

This map shows the geographic impact of Sara Steffanoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Steffanoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Steffanoni more than expected).

Fields of papers citing papers by Sara Steffanoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Steffanoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Steffanoni. The network helps show where Sara Steffanoni may publish in the future.

Co-authorship network of co-authors of Sara Steffanoni

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Steffanoni. A scholar is included among the top collaborators of Sara Steffanoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Steffanoni. Sara Steffanoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirosa, Maria Cristina, Sara Steffanoni, Anna Vanazzi, et al.. (2024). Superior prognostic accuracy of FIGO staging system in primary female genital tract lymphomas: A retrospective study (IELSG35). Hematological Oncology. 42(6). e3312–e3312. 2 indexed citations
2.
Marzullo, Aldo, Paolo Zaffino, Sara Steffanoni, et al.. (2023). Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. Bioengineering. 10(3). 285–285. 15 indexed citations
4.
Marzullo, Aldo, Maria Francesca Spadea, Nicoletta Anzalone, et al.. (2023). Deep learning-based overall survival prediction model in patients with rare cancer: a case study for primary central nervous system lymphoma. International Journal of Computer Assisted Radiology and Surgery. 18(10). 1849–1856. 6 indexed citations
5.
Guidotti, Francesca, et al.. (2022). Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapy. Journal of Oncology Pharmacy Practice. 28(4). 969–971.
6.
Ferreri, Andrés J.M., Piera Angelillo, Chiara Cattaneo, et al.. (2022). Safety and efficacy of a dose-dense short-term therapy in patients with MYC-translocated aggressive lymphoma. Blood Advances. 6(22). 5811–5820.
7.
Guidotti, Francesca, et al.. (2021). Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature. Blood Cells Molecules and Diseases. 92. 102615–102615. 9 indexed citations
8.
Calimeri, Teresa, Sara Steffanoni, Filippo Gagliardi, A. Chiara, & Andrés J.M. Ferreri. (2021). How we treat primary central nervous system lymphoma. ESMO Open. 6(4). 100213–100213. 55 indexed citations
9.
Sferruzza, Giacomo, Teresa Calimeri, Sara Steffanoni, et al.. (2021). Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness. European Journal of Radiology. 143. 109945–109945. 19 indexed citations
10.
Calimeri, Teresa, Sara Steffanoni, Marco Foppoli, Maurilio Ponzoni, & Andrés J.M. Ferreri. (2021). Implications of recent molecular achievements in early diagnosis and precision treatments for primary CNS lymphoma. Expert Opinion on Therapeutic Targets. 25(9). 749–760. 1 indexed citations
11.
Steffanoni, Sara, Teresa Calimeri, Nicoletta Anzalone, et al.. (2021). A narrative review of consolidation strategies for young and fit patients with newly-diagnosed primary central nervous system lymphoma. Expert Review of Hematology. 15(1). 33–43. 3 indexed citations
12.
Steffanoni, Sara & Tracy T. Batchelor. (2021). Targeting Bruton's tyrosine kinase in primary central nervous system lymphoma. Current Opinion in Neurology. 34(6). 848–856. 1 indexed citations
13.
Steffanoni, Sara, et al.. (2021). Narrative review: secondary central nervous system lymphoma. 5. 5–5. 2 indexed citations
14.
Steffanoni, Sara, et al.. (2016). SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW. SHILAP Revista de lepidopterología.
15.
Steffanoni, Sara, et al.. (2016). SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW. Mediterranean Journal of Hematology and Infectious Diseases. 8(1). e2016062–e2016062. 6 indexed citations
16.
Steffanoni, Sara, Michele Ghielmini, & Alden A. Moccia. (2015). Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options. Expert Review of Anticancer Therapy. 15(11). 1337–1349. 4 indexed citations
18.
Martinelli, Giovanni, Gerard E. Ryan, John F. Seymour, et al.. (2009). Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Annals of Oncology. 20(12). 1993–1999. 64 indexed citations
19.
Nassi, Luca, Laura Lavinia Travaini, Sara Steffanoni, et al.. (2008). Interim 18f[FDG] Positron Emission Tomography in Patients with Diffuse Large B-Cell Lymphoma. Blood. 112(11). 3607–3607. 4 indexed citations
20.
Azim, Hatem A., Giancarlo Pruneri, Paola Rafaniello Raviele, et al.. (2007). ERCC1 Expression in Diffuse Large B-Cell Lymphoma Patients Treated with a Cisplatin-Based Regimen : A Brief Communication.. PubMed. 19(3). 176–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026